Key facts
- This page summarizes Michael T. Maloney's Form 3 filing for TENET HEALTHCARE CORP (THC).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 09 Mar 2026, 20:00.
Michael T. Maloney - 27 Feb 2026 Form 3 Insider Report for TENET HEALTHCARE CORP (THC)
- Reporting relationship
- EVP, Corporate Development
- Issuer ticker
- THC
- Reported as of
- 27 Feb 2026
- Net transaction value
- $0
- Reporting owner signature
- Chad J. Wiener, as Attorney-in-Fact for Michael T. Maloney
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Michael T. Maloney filed Form 3 for TENET HEALTHCARE CORP (THC) on 09 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002117364
Primary reporting owner
Maloney Michael T.
- Relationship
- EVP, Corporate Development
- Address
- 14201 DALLAS PARKWAY, DALLAS
- Signature
- Chad J. Wiener, as Attorney-in-Fact for Michael T. Maloney
- Signature date
- 09 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
THC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 101,990
- Date
- 27 Feb 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
THC
holding
Derivative
2018 February Performance Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,876
- Exercise price
- $20.60
THC
holding
Derivative
2019 February Performance Stock Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,682
- Exercise price
- $28.26
THC
holding
Derivative
2024 February Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,737
- Exercise price
- Footnotes
- F1, F2
THC
holding
Derivative
2025 February Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,068
- Exercise price
- Footnotes
- F2, F3
THC
holding
Derivative
2026 February Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,013
- Exercise price
- Footnotes
- F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents unvested February 2024 time-based restricted stock units that vest in full on February 28, 2027.
Footnote F2
Restricted stock units are settled in shares of the Company's common stock upon vesting.
Footnote F3
Represents unvested February 2025 time-based restricted stock units that vest in equal remaining increments on February 24, 2027, and February 24, 2028.
Footnote F4
Represents unvested February 2026 time-based restricted stock units that vest in one-third increments on February 27, 2027, February 27, 2028, and February 27, 2029.